CBFβ–SMMHC in inv(16) AML: Fusion biology, RUNX1 dysregulation, and therapeutic targeting of a leukemogenic protein–protein interaction

Pathology - Research and Practice 2026

View at publisher
Authors: Emadeldin M. Kamel, Sally Mostafa Khadrawy, Mohamed A.M. Ali, Noha A. Ahmed, Saleh Alkhedhairi, Faris F. Aba Alkhayl, Al Mokhtar Lamsabhi
DOI: 10.1016/j.prp.2026.156607
Cited by: 1
References: 109

Fields of Study & Subjects

Acute Myeloid Leukemia Research Protein Degradation and Inhibitors Histone Deacetylase Inhibitors Research

Publication details

Journal / source
Pathology - Research and Practice
Publisher
Elsevier BV
Volume
286
Pages
156607–156607
Publication date
1 July 2026
Language
EN